2 years ago

TidalSense Raises $9.3 Million for Handheld COPD Diagnostic Device

  • Cambridge-based health tech company TidalSense has raised $9.3 million in funding to further develop its handheld medical device, N-Tidal, for COPD diagnosis

  • The device offers a more accurate and efficient alternative to traditional spirometers, measuring CO2 levels and detecting changes in lung function in under five minutes

  • The company claims its device has been benchmarked on over 1,000 patients with high accuracy in diagnosing COPD.

      • ProblemHealthcare

      "Diagnosing COPD currently relies on outdated spirometer technology from the 1840s, which is inaccurate, time-consuming, and doesn't measure crucial data points like CO2 levels, leading to delayed diagnosis and inadequate management of this life-threatening condition."

      Solution

      "TidalSense offers an affordable, portable, and easy-to-use handheld device that provides faster and more accurate COPD diagnosis by measuring CO2 levels and sending data to a cloud-based platform, enabling timely intervention and improved patient outcomes."

      Covered on